Stocks
Denali Therapeutics (DNLI) P/FCF US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| P/FCF | -9.83 | 22.1 | -24.6 | -13.3 | -7.95 | -6.89 | ||
| Changes by years, y/y, % | -124% | -325% | -212% | -46% | -40% | |||
Denali Therapeutics. P/FCF
Denali Therapeutics. P/FCF, changes, %
Denali Therapeutics (DNLI) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| P/FCF | -12.7 | -12.6 | -8.17 | -8.00 | -7.21 | -6.89 | ||
| Changes by years, y/y, % | -22% | -19% | -45% | -43% | -43% | |||
| Changes by quarters, q/q, % | -10% | -1% | -35% | -2% | -10% | |||
